GSK to collaborate with the University of Edinburgh on acute pancreatitis
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and the University of Edinburgh have entered into an agreement to discover and develop medicines with the potential to treat severe acute pancreatitis.